Högskolan i Skövde

his.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Inhibition of TrxR1 induces SecTRAPs which promote cytotoxicity and reduce migration in KRAS-driven Lung Cancer
Högskolan i Skövde, Institutionen för hälsovetenskaper.
2020 (engelsk)Independent thesis Basic level (degree of Bachelor), 20 poäng / 30 hpOppgave
Abstract [en]

To thrive and proliferate, cancer cells must counteract the oxidative stress, which is upregulated in their environment. To achieve this, antioxidants must be obtained, or their synthesis upregulated. One antioxidant system that is commonly upregulated by cancer cells is the thioredoxin system. Proteins within this system often contain selenium. Two of these, thioredoxin-1 (TRX1) and thioredoxin reductase-1 (TrxR1), are integral in the regulation of ROS. The inhibition of TrxR1 by electrophilic compounds results in selenium compromised thioredoxin reductase derived apoptotic proteins, otherwise known as SecTRAPs. The propagation of these SecTRAPs disrupts the redox balance in the cells resulting in cytotoxic effects, including generation of ROS, membrane instability and cell death. As such, their generation inhibits cell growth and could potentially be therapeutically exploited in future anti-cancer treatments. This study assesses how selenium pre-treatment of lung cancer cells enhances the effect of TrxR1 inhibitors (TRI) such as TRI-1 and auranofin, among others. It measures the effect of inhibition by analysing cell viability, proliferation, and migration. Results indicate that selenium pre-treatment increases the effects of TRI-1 on both migration and proliferation of lung cancer cells. Viability assays indicate 2.5μM as a sub-lethal dose of TRI-1 and auranofin. Effects of TRI-1 at this concentration were used to analyse cytotoxic effects. Migration was reduced in cells with up-regulated TrxR1 synthesis but increased in cells with basal concentrations, while proliferation was decreased by TRI-1 in all cell lines and pre-treatment conditions. Optimization of western blot protocols was also completed for future protein expression analysis.

sted, utgiver, år, opplag, sider
2020. , s. 47
HSV kategori
Identifikatorer
URN: urn:nbn:se:his:diva-18683OAI: oai:DiVA.org:his-18683DiVA, id: diva2:1449319
Eksternt samarbeid
Sayin Group, Sahlgrenska Center for Cancer Research
Fag / kurs
Biomedicine/Medical Science
Utdanningsprogram
Biomedicine - Study Programme
Veileder
Examiner
Tilgjengelig fra: 2020-06-30 Laget: 2020-06-30 Sist oppdatert: 2020-06-30bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Av organisasjonen

Søk utenfor DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric

urn-nbn
Totalt: 293 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf